Exelon (NASDAQ:EXC - Get Free Report) will likely be issuing its Q1 2025 quarterly earnings data before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of $0.71 per share and revenue of $6.30 billion for the quarter. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS.
Exelon (NASDAQ:EXC - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same period last year, the firm earned $0.60 EPS. On average, analysts expect Exelon to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Exelon Price Performance
Shares of NASDAQ EXC opened at $46.87 on Thursday. The company has a market capitalization of $47.32 billion, a price-to-earnings ratio of 19.13, a PEG ratio of 2.86 and a beta of 0.39. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.87 and a quick ratio of 0.78. Exelon has a 1-year low of $34.01 and a 1-year high of $48.11. The business has a 50-day moving average of $44.59 and a 200-day moving average of $40.94.
Exelon Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a $0.40 dividend. This is an increase from Exelon's previous quarterly dividend of $0.38. The ex-dividend date of this dividend was Monday, February 24th. This represents a $1.60 annualized dividend and a yield of 3.41%. Exelon's dividend payout ratio (DPR) is 65.31%.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on EXC shares. Morgan Stanley lifted their target price on Exelon from $46.00 to $48.00 and gave the stock an "equal weight" rating in a research report on Thursday, March 20th. UBS Group lifted their target price on Exelon from $45.00 to $47.00 and gave the company a "neutral" rating in a research note on Friday, March 21st. BMO Capital Markets reaffirmed an "outperform" rating on shares of Exelon in a report on Tuesday, February 4th. Barclays lifted their target price on Exelon from $42.00 to $48.00 and gave the company an "overweight" rating in a research note on Tuesday, February 25th. Finally, Evercore ISI reaffirmed an "in-line" rating and issued a $48.00 price target (up from $46.00) on shares of Exelon in a research note on Tuesday, April 15th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $45.63.
Get Our Latest Report on EXC
Insider Activity
In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the transaction, the executive vice president now directly owns 2,271 shares of the company's stock, valued at $92,134.47. This represents a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.10% of the stock is currently owned by corporate insiders.
About Exelon
(
Get Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.